International legal practice Osborne Clarke has advised ViroClinics Biosciences, a leading virology contract research organization, and American private equity company Summit Partners, on the acquisition of DDL Diagnostic Laboratory.
DDL is a Dutch-based leading diagnostic solutions provider and an expert laboratory in advanced (molecular) diagnostic testing.
Both ViroClinics and DDL operate globally, serving leading biopharmaceutical companies active in the field of microbial vaccines and anti-virals. ViroClinics is the global leader in influenza and other viral targets, such as RSV and Polio, while DDL also specialises in the fields of Hepatitis and HPV. Both laboratories are currently committing to testing anti-virals, immune modulators and vaccines in the battle against COVID-19.
ViroClinics and Summit were advised by Osborne Clarke in Amsterdam. The team was led by corporate Partner Cristine Brinkman and included Senior Associate Marie-Louise Weeda, Associates Niels Dolk and Guusje Cornelissen, Partner and Civil-law Notary Cars-Jan van Gool and Prospective Civil-law Notary Arlette Vrolijk. Tax Partner Job van der Pol, employment Partner Jorgo Tsiris and Associates Sabine van Baren (employment) and Barry Breedijk (IP/data protection) also advised.
Osborne Clarke is widely recognised as a leading European law firm for companies operating in the life science and healthcare sector team. Its international life science and healthcare sector team has a strong track record of providing highly sophisticated advice to investors and biotech clients on cutting-edge issues, across multiple service lines.